References:

  1. WHO Classification of Tumours Editorial Board: Digestive System Tumours, 5th Edition, 2019
  2. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259-1269.
  3. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23(4):377-389. doi:10.1097/00000478-199904000-00002
  4. Rossi S, Miceli R, Messerini L, et al. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011;35(11):1646-1656. doi:10.1097/PAS.0b013e31822d63a7
  5. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70-83. doi:10.1053/j.semdp.2006.09.001
  6. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466-1478. doi:10.5858/2006-130-1466-GSTROM
  7. Organisation mondiale de la santé, Centre international de recherche sur le cancer, eds. Digestive System Tumours. 5th ed. International agency for research on cancer; 2019.
  8. Cibas ES, Ducatman BS. Cytology: Diagnostic Principles and Clinical Correlates. Fifth edition. Elsevier; 2021.
  9. Wieczorek TJ, Faquin WC, Rubin BP, Cibas ES. Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma. Cancer. 2001;93(4):276-287. doi:10.1002/cncr.9042
  10. Dodd LG, Nelson RC, Mooney EE, Gottfried M. Fine-needle aspiration of gastrointestinal stromal tumors. Am J Clin Pathol. 1998;109(4):439-443. doi:10.1093/ajcp/109.4.439
  11. Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, Heinrich MC. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer. 2001;93(4):269-275. doi:10.1002/cncr.9041
  12. Boggino HE, Fernandez MP, Logroño R. Cytomorphology of gastrointestinal stromal tumor: diagnostic role of aspiration cytology, core biopsy, and immunochemistry. Diagn Cytopathol. 2000;23(3):156-160. doi:10.1002/1097-0339(200009)23:3<156::aid-dc3>3.0.co;2-p
  13. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008;32(2):210-218. doi:10.1097/PAS.0b013e3181238cec
  14. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165(1):107-113. doi:10.1016/S0002-9440(10)63279-8
  15. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33(9):1401-1408. doi:10.1097/PAS.0b013e3181a90e1a
  16. Novelli M, Rossi S, Rodriguez-Justo M, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010;57(2):259-270. doi:10.1111/j.1365-2559.2010.03624.x
  17. Li SQ, O’Leary TJ, Sobin LH, Erozan YS, Rosenthal DL, Przygodzki RM. Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors. Acta Cytol. 2000;44(6):981-986. doi:10.1159/000328620
  18. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52-68. doi:10.1097/01.pas.0000146010.92933.de
  19. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708-710. doi:10.1126/science.1079666
  20. Corless CL, Schroeder A, Griffith D, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(23):5357-5364. doi:10.1200/JCO.2005.14.068
  21. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577-580. doi:10.1126/science.279.5350.577
  22. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61(22):8118-8121.
  23. Joensuu H, Rutkowski P, Nishida T, et al. KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(6):634-642. doi:10.1200/JCO.2014.57.4970
  24. Emile JF, Brahimi S, Coindre JM, et al. Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Med Oncol. 2012;29(3):1765-1772. doi:10.1007/s12032-011-0074-y
  25. Jakhetiya A, Garg PK, Prakash G, Sharma J, Pandey R, Pandey D. Targeted therapy of gastrointestinal stromal tumours. World J Gastrointest Surg. 2016;8(5):345-352. doi:10.4240/wjgs.v8.i5.345
  26. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw JNCCN. 2007;5 Suppl 2:S1-29; quiz S30.
  27. Gaal J, Stratakis CA, Carney JA, et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol Off J U S Can Acad Pathol Inc. 2011;24(1):147-151. doi:10.1038/modpathol.2010.185
  28. Gill AJ, Chou A, Vilain R, et al. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol. 2010;34(5):636-644. doi:10.1097/PAS.0b013e3181d6150d
  29. Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol. 2011;35(11):1712-1721. doi:10.1097/PAS.0b013e3182260752
  30. Pasini B, McWhinney SR, Bei T, et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet EJHG. 2008;16(1):79-88. doi:10.1038/sj.ejhg.5201904
  31. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266(1):43-52. doi:10.1111/j.1365-2796.2009.02110.x
  32. Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc. 1999;74(6):543-552. doi:10.4065/74.6.543
  33. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30(1):90-96. doi:10.1097/01.pas.0000176433.81079.bd
  34. Carney JA, Sheps SG, Go VL, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med. 1977;296(26):1517-1518. doi:10.1056/NEJM197706302962609
  35. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Am J Surg Pathol. 2017 May;41(5):577-585. doi: 10.1097/PAS.0000000000000807. PMID: 28288036; PMCID: PMC5391299.
  36. Wang X, Abi-Raad R, Tang H, Cai G. Ki-67 index assessment on FNA specimens of gastrointestinal stromal tumor: Correlation with mitotic rate and potential predictive value for risk stratification. Cancer Cytopathol. 2022 Dec;130(12):974-982. doi: 10.1002/cncy.22630. Epub 2022 Jul 25. PMID: 35876606.
  37. Shimizu T, Koshita S, Ohira T, Harada Y, Kanno Y, Ogawa T, Yamagata T, Kusunose H, Sakai T, Tsuchiya T, Oikawa M, Noda Y, Sawai T, Ito K. Endoscopic Ultrasonography-guided Fine-needle Aspiration Cytology Combined with a Cell-block Method for Gastrointestinal Subepithelial Lesions. Intern Med. 2022 Apr 1;61(7):935-942. doi: 10.2169/internalmedicine.7889-21. Epub 2021 Sep 11. PMID: 34511568; PMCID: PMC9038475.
  38. Meara RS, Cangiarella J, Simsir A, Horton D, Eltoum I, ChhiengDC. Prediction of aggressiveness of gastrointestinal stromal tumorsbased on immunostaining with bcl-2, Ki-67 and p53. Cytopathology.2007;18(5):283–289.
  39. Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumorswith EUS-guided fine-needle aspiration with immunohistochemicalanalysis. Gastrointest Endosc. 2002;55(1):37–43
  40. Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013 Feb;45(2):131-2. doi: 10.1038/ng.2522. Epub 2013 Jan 13. PMID: 23313954; PMCID: PMC3984043.
  41. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005 Oct;29(10):1340-7. doi: 10.1097/01.pas.0000170343.09562.39. PMID: 16160477.
  42. Ylagan LR, Bhalla S. Fine needle aspiration cytology of a dedifferentiated liposarcoma: report of a case with histologic and immunohistochemical follow-up. Acta Cytol. 2001 Jul-Aug;45(4):641-4. doi: 10.1159/000327880. PMID: 11480734.
  43. McHugh KE, Odronic SI, Smith A, Springer B, Aramouni G, Chute DJ, Reynolds JP. Spindle cell neoplasms of the upper gastrointestinal tract, hepatobiliary tract, and pancreas by fine needle aspiration: A single institutional experience of 15 years with follow-up data. Diagn Cytopathol. 2021 Sep;49(9):987-996. doi: 10.1002/dc.24801. Epub 2021 May 18. PMID: 34003599.
  44. Taşkın, O. Ç., Armutlu, A., Adsay, V., Aslan, F., & Kapran, Y. (2020). Clinicopathologic and immunohistochemical characteristics of upper gastrointestinal leiomyomas harboring interstitial cells of Cajal: A potential mimicker of gastrointestinal stromal tumor. Annals of diagnostic pathology, 45, 151476. https://doi.org/10.1016/j.anndiagpath.2020.151476